Search for dissertations about: "schizophrenia 2012"

Showing result 1 - 5 of 12 swedish dissertations containing the words schizophrenia 2012.

2. 1. Asperger syndrome and schizophrenia. Psychiatric and social cognitive aspects

   Author : Tove Lugnegård; Göteborgs universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Asperger syndrome; Autism spectrum; Schizophrenia; Autism-spectrum Quotient; Animations Task; Reading the Mind in the Eyes Test; Personality Disorder;

   Abstract : Background: Asperger syndrome (AS) and schizophrenia are psychiatric disorders often implying low global social functioning and a life-long course. Both disorders are of neurodevelopmental origin and genetic factors are prominent. READ MORE

4. 2. Autism and early development in adults with schizophrenia. Methodological and clinical aspects

   Author : Maria Unenge Hallerbäck; Göteborgs universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Schizophrenia; Asperger syndrome; Austism spectrum disorder; ADHD; Reading the Mind in the Eyes Test; Diagnostic Interview for Social and Communication Disorders; Nicotine;

   Abstract : Background: Typical symptoms of schizophrenia usually appear in young adult life, but problems with social interaction, activity control, motor performance, and cognition have often been noted in childhood. This thesis explores similarities and differences regarding early development between individuals with clinical diagnoses of schizophrenia and Asperger syndrome (a clinical variant of autism spectrum disorder/ASD). READ MORE

5. 3. Illness Management and Recovery : Implementation and evaluation of a psychosocial program for schizophrenia and schizoaffective disorder

   Author : Rickard Färdig; Anders Fredriksson; Lewander Tommy; Lennart Melin; Lars Hansson; Uppsala universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; illness management and recovery; IMR; recovery; schizophrenia; schizoaffective; evidence-based; psychosocial; intervention outcome; neurocognition; remission; IMRS; psychometric properties; reliability; validity; Medical Science; Medicinsk vetenskap;

   Abstract : The aim of the present thesis was to examine the effectiveness of the Illness Management and Recovery (IMR) program for teaching clients with schizophrenia or schizoaffective disorder to better manage their illness and to promote recovery. This was accomplished through an examination of the program’s effects on psychosocial functioning and psychopathology, the evaluation of general and specific impact of neurocognition on learning the fundamentals of illness self-management, and the impact of symptom severity on outcome of the IMR program. READ MORE

6. 4. Functional Analysis of the Vesicular Glutamate Transporter 2 in Specific Neuronal Circuits of the Brain

   Author : Karin Nordenankar; Åsa Wallén-Mackenzie; Rainer Spanagel; Uppsala universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Addiction; amphetamine; affective behaviour; cocaine; cognitive behaviour; conditional knockout mouse; dopamine; operant self-administration; reward system; schizophrenia; Neuroscience; Neurovetenskap;

   Abstract : A key issue in neuroscience is to determine the connection between neuronal circuits and behaviour. In the adult brain, all neuronal circuits include a glutamatergic component. READ MORE

7. 5. Clinical Pharmacogenetics of Olanzapine : with Focus on FMO Gene Polymorphisms

   Author : Mao Mao Söderberg; Marja-Liisa Dahl; Maria Gabriella Scordo; Inger Johansson; Uppsala universitet; []
   Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; olanzapine; pharmacogenetics; drug metabolism; schizophrenia; therapeutic drug monitoring; FMO1; FMO3; CYP1A2; UGT1A4; Clinical Pharmacology; Klinisk farmakologi;

   Abstract : Pharmacogenetics is the study of variability in drug response attributed to genetic variation. Olanzapine (OLA) is a widely used antipsychotic drug for schizophrenia treatment. The pharmacokinetics of OLA display large inter-individual variation leading to multiple-fold differences in drug exposure between patients at a given dose. READ MORE